Synthimed Labs Private Limited
Hrishikesh Samant is an experienced professional with a strong background in finance and consulting. Currently serving as a Board Member for Synthimed Labs Private Limited and Livasa Hospitals since 2024, Hrishikesh has also held the position of Director and Vice President at the India Resurgence Fund since 2017. Prior roles include Associate at Bain Capital and Senior Associate at The Boston Consulting Group, where knowledge in accounting and finance was further developed. Hrishikesh began a career in finance as an Audit Intern at Manish Modi And Associates. Educational qualifications include a Chartered Accountant designation from The Institute of Chartered Accountants of India and a Bachelor's Degree in Accounting and Finance from Podar College of Commerce and Economics.
This person is not in the org chart
This person is not in any teams
Synthimed Labs Private Limited
In March 2024, Synthimed took over the esteemed legacy established by Ind-Swift Laboratories since 1995. Our primary focus is on nurturing a strong domestic presence while strategically expanding into established regulated markets and emerging economies. Each step forward stands as a testament to the dedication of our united team, whose unwavering commitment drives us toward new heights of achievement. Equipped with cutting-edge manufacturing facilities, an independent R&D Centre, and a proven track record of regulatory approvals, Synthimed is dedicated to becoming a reliable partner in the global pharmaceutical arena. Our strengths lie in our capabilities for API development, production of finished dosage forms, non-infringing processes, and world-class facilities for contract manufacturing. As we move forward, Synthimed remains steadfast in upholding the highest standards of quality and innovation, ensuring our ongoing contribution to the advancement of healthcare worldwide.